Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Incidence rates of thrombosis with thrombocytopenia syndrome (TTS) among adults in United States commercial and Medicare claims databases, 2017-2020.
Lloyd PC, Lufkin B, Moll K, Ogilvie RP, McMahill-Walraven CN, Beachler DC, Kelman JA, Shi X, Hobbi S, Amend KL, Djibo DA, Shangguan S, Shoaibi A, Sheng M, Secora A, Zhou CK, Kowarski L, Chillarige Y, Forshee RA, Anderson SA, Muthuri S, Seeger JD, Kline A, Reich C, MaCurdy T, Wong HL. Lloyd PC, et al. Among authors: lufkin b. Vaccine. 2024 Mar 19;42(8):2004-2010. doi: 10.1016/j.vaccine.2024.02.017. Epub 2024 Feb 22. Vaccine. 2024. PMID: 38388240
Background rates of adverse events of special interest for COVID-19 vaccine safety monitoring in the United States, 2019-2020.
Moll K, Lufkin B, Fingar KR, Ke Zhou C, Tworkoski E, Shi C, Hobbi S, Hu M, Sheng M, McCarty J, Shangguan S, Burrell T, Chillarige Y, Beers J, Saunders-Hastings P, Muthuri S, Edwards K, Black S, Kelman J, Reich C, Amend KL, Djibo DA, Beachler D, Ogilvie RP, Secora A, McMahill-Walraven CN, Seeger JD, Lloyd P, Thompson D, Dimova R, MaCurdy T, Obidi J, Anderson S, Forshee R, Wong HL, Shoaibi A. Moll K, et al. Among authors: lufkin b. Vaccine. 2023 Jan 9;41(2):333-353. doi: 10.1016/j.vaccine.2022.11.003. Epub 2022 Nov 8. Vaccine. 2023. PMID: 36404170 Free PMC article.
Surveillance of COVID-19 vaccine safety among elderly persons aged 65 years and older.
Wong HL, Tworkoski E, Ke Zhou C, Hu M, Thompson D, Lufkin B, Do R, Feinberg L, Chillarige Y, Dimova R, Lloyd PC, MaCurdy T, Forshee RA, Kelman JA, Shoaibi A, Anderson SA. Wong HL, et al. Among authors: lufkin b. Vaccine. 2023 Jan 9;41(2):532-539. doi: 10.1016/j.vaccine.2022.11.069. Epub 2022 Dec 1. Vaccine. 2023. PMID: 36496287 Free PMC article.
Trends in Erythropoiesis-stimulating agent use and blood transfusions for chemotherapy-induced anemia throughout FDA's risk evaluation and mitigation strategy lifecycle.
Vega A, Zhang R, Wong HL, Wernecke M, Alexander M, Feng Y, Lo AC, Lufkin B, Ryan Q, Izem R, MaCurdy TE, Kelman JA, Graham DJ. Vega A, et al. Among authors: lufkin b. Pharmacoepidemiol Drug Saf. 2021 May;30(5):626-635. doi: 10.1002/pds.5202. Epub 2021 Feb 22. Pharmacoepidemiol Drug Saf. 2021. PMID: 33534188
Effectiveness of Bivalent mRNA COVID-19 Vaccines in Preventing COVID-19-Related Thromboembolic Events Among Medicare Enrollees Aged ≥65 Years and Those with End Stage Renal Disease - United States, September 2022-March 2023.
Payne AB, Novosad S, Wiegand RE, Najdowski M, Gomes DJ, Wallace M, Kelman JA, Sung HM, Zhang Y, Lufkin B, Chillarige Y, Link-Gelles R. Payne AB, et al. Among authors: lufkin b. MMWR Morb Mortal Wkly Rep. 2024 Jan 11;73(1):16-23. doi: 10.15585/mmwr.mm7301a4. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38206877 Free PMC article.
12 results